Recent research bolsters the case that radiotherapy to treat primary endometrial cancer is associated with an increased risk ...

Tina Willits In “properly selected” patients, however, Slomovitz believes immunotherapy can prolong both the time to cancer ...

ESPN analyst Randy Moss, who retired from the NFL in 2012 after 14 seasons, revealed that he is a “cancer survivor” and will ...

The cause is near to his heart, as Gamblin is a cancer survivor himself – he was diagnosed with testicular cancer in 2018 after noticing a lump. "I thought it was probably nothing, but I was ...

Background Endometrial cancer is the most common gynecologic ... Univariate and multivariate analyses were performed for overall survival, disease-free survival, and progression-free survival ...

Overweight and obesity were associated with improved survival after treatment of endometrial cancer with immunotherapy, especially in high-risk subtypes, when compared to patients with a normal BMI.

Approximately 121,000 people are diagnosed with primary advanced or recurrent endometrial cancer each year in Europe ...

First approved in 2021, Jemperli has now become a cornerstone of GSK’s cancer business, earning more than $160 million in the ...

If caught early, cervical cancer has a very high five-year survival rate — more than 90 ... gynecological cancers like ovarian, cervical and uterine cancers received some of the smallest amounts ...

The addition of a progestin to estrogen in HRT in women with an intact uterus reduces the risk of endometrial hyperplasia and cancer but increases the risk of breast cancer. The increase in ...

GSK said the European Union's Committee for Medicinal Products for Human Use has recommended expanding approval of Jemperli in combination with chemotherapy for treatment of adults with primary ...